Therapy with metronomic cyclophosphamide (mCyc) in metastatic castrate resistant prostate cancer (mCRPC) and genomic correlates

Authors

• William Kelly

Publication/Presentation Date

5-2023

Volume

41

Issue

16

Published In/Presented At

DOI: 10.1200/JCO.2023.41.16_suppl.e17041

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article